Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 8, 2002, Pages 698-704

  Chang Claude, Jenny ^a   Kropp, Silke ^a   Jäger, Birgit ^a   Bartsch, Helmut ^a   Risch, Angela ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; GENE PRODUCT; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ACETYLATOR PHENOTYPE; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PASSIVE SMOKING; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING CESSATION; SMOKING HABIT;

ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; SMOKING CESSATION; TOBACCO SMOKE POLLUTION;

EID: 0036328468     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cigarette smoking and urinary estrogens
2. Smoking and endogenous sex hormones in men and women
3. Nicotine in breast fluid of nonlactating women
4. Smoking, menopause, and breast cancer
5. Cancer mortality in nonsmoking women with smoking husbands based on a large-scale cohort study in Japan
6. Passive smoking in adulthood and cancer risk
7. Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women
8. Relation of breast cancer with passive and active exposure to tobacco smoke
9. Breast cancer, cigarette smoking, and passive smoking
10. Active and passive cigarette smoking and the occurrence of breast cancer
11. Passive and active smoking and breast cancer risk in Canada, 1994-97
12. Carcinogen-DNA adducts in human breast tissue
13. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer
14. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer
15. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk
16. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer
17. Cigarette smoking. NAT2 genetic polymorphisms, and breast cancer risk
18. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer
19. Cigarette smoking. N-acetyltransferases 1 and 2, and breast cancer risk
20. Breast cancer and active and passive smoking: The role of the N-acetyltransferase 2 genotype
21. Breastfeeding and breast cancer risk by age 50 among women in Germany
22. Relevance of N-acetyltransferases 1 and 2 (NAT1. NAT2) genetic polymorphisms in non-small cell lung cancer
23. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity
24. Genotyping human polymorphic arylamine N-acetyltransferase: Identification of new slow allotypic variants
25. Arylamine N-acetyltransferase activity in man
26. Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype
27. Chemistry and analysis of tobacco smoke
28. 32P-postlabelling analysis of DNA adducted with urinary mutagens from smokers of black tobacco
29. 32P-postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) as a major DNA-damaging agent
30. Excretion of mutagens in human urine after passive smoking
31. Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breast
32. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
33. N-Acetyltransferases, sulphotransferases and heterocyclic amine activation in the breast
34. Simultaneous determination of aminoα-carbolines and amino-γ-carbolines in cigarette smoke condensate by highperformance liquid chromatography
35. Contens in foods, beverages and tobacco
36. In vitro bioactivation of N-hydroxy-2-amino-α-carboline
37. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland
38. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells
39. Histological localization of messenger RNAs for rat acetyltransferases that acetylate serotonin and genotoxic arylamines
40. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps
41. Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women
42. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms
43. Survival of women with breast cancer in relation to smoking